幻覚剤：世界市場の展望

当レポートでは、世界の幻覚剤の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種セグメント・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 市場の見通し

• 市場スナップショット

第2章 エグゼクティブサマリー

第3章 市場概要

• 市場概要
• 市場力学
  • 市場促進要因
  • 市場抑制要因

第4章 市場内訳：薬剤タイプ別

• ケタミン
• ガンマヒドロキシ酪酸（GHB）
• その他

第5章 市場内訳：用途別

• 治療抵抗性うつ病・不安症
• アヘン中毒
• PTSD
• ナルコレプシー
• その他

第6章 市場内訳：地域別

• 北米
• 欧州
• アジア太平洋
• その他の地域

第7章 幻覚剤と精密医療

第8章 産業構造

• 企業ランキング
• 最近の主な展開

第9章 企業プロファイル

• CELON PHARMA S.A.
• CYBIN CORP.
• HIKMA PHARMACEUTICALS PLC.
• JAZZ PHARMACEUTICALS INC.
• MIND MEDICINE INC.
• PFIZER INC.
• PHARMATHER HOLDINGS LTD.
• REVIVE THERAPEUTICS LTD.

第10章 プロジェクトの範囲・調査手法

List of Tables

• Summary Table : Global Market for Psychedelic Drugs, by Region, Through 2027
• Table 1 : Global Market for Psychedelic Drugs, by Drug Type, Through 2027
• Table 2 : Global Market for Psychedelic Drugs, by Application, Through 2027
• Table 3 : Global Market for Psychedelic Drugs, by Region, Through 2027
• Table 4 : North American Market for Psychedelic Drugs, by Drug Type, Through 2027
• Table 5 : North American Market for Psychedelic Drugs, by Application, Through 2027
• Table 6 : European Market for Psychedelic Drugs, by Drug Type, Through 2027
• Table 7 : European Market for Psychedelic Drugs, by Application, Through 2027
• Table 8 : Asia-Pacific Market for Psychedelic Drugs, by Drug Type, Through 2027
• Table 9 : Asia-Pacific Market for Psychedelic Drugs, by Application, Through 2027
• Table 10 : RoW Market for Psychedelic Drugs, by Drug Type, Through 2027
• Table 11 : RoW Market for Psychedelic Drugs, by Application, Through 2027
• Table 12 : Ranking of Psychedelic Drug Companies, 2021
• Table 13 : Recent Key Developments in the Global Market for Psychedelic Drugs
• Table 14 : Celon Pharma: Products
• Table 15 : Cybin Corp.: Pipeline Products
• Table 16 : Hikma Pharmaceuticals: Products
• Table 17 : Jazz Pharmaceuticals Inc.: Products
• Table 18 : Mind Medicine: Pipeline Products
• Table 19 : Pfizer Inc.: Product
• Table 20 : PharmaTher Holdings Ltd.: Pipeline Product

List of Figures

• Summary Figure A : Global Market Shares of Psychedelic Drugs, by Region, 2021
• Summary Figure B : Growth Rates of the North American, European and Asia-Pacific Markets for Psychedelic Drugs, 2022-2027
• Figure 1 : Global Market Shares of Psychedelic Drugs, by Drug Type, 2021
• Figure 2 : Global Market Shares of Psychedelic Drugs, by Application, 2021
• Figure 3 : Global Market for Psychedelic Drugs, by Region
• Figure 4 : Global Market Shares of Psychedelic Drugs, by Region, 2021

Highlights:

The report provides an overview of the global psychedelic drugs market. This report includes sales forecasts and trends in the market for psychedelic drugs through 2027. It discusses leading companies in the market, product segments, supporting technologies, market dynamics, competitive intelligence and regional trends.

Report Scope:

This report includes sales forecasts and trends in the market for psychedelic drugs through 2027. It discusses leading companies in the market, product segments, supporting technologies, market dynamics, competitive intelligence and regional trends. It also discusses market the competitive scenarios that will form the base data for qualitative analysis and market estimates.

In this report, the global market for psychedelic drugs is segmented into four geographic regions: North America, Europe, Asia and RoW (South America, the Middle East and Africa).

Report Includes:

• 12 data tables and 9 additional tables
• A brief general outlook of the global market for psychedelic drugs within the biopharmaceutical industry
• Analyses of the global market trends, with historic sales data for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Highlights of the current and future market potential of psychedelic drugs, along with detailed analyses of the competitive environment, regulatory scenario, pipeline analysis, technological advancement and market dynamics
• Estimation of the actual market size and revenue forecast for global psychedelic drugs market in USD million values, and corresponding market share analysis based on drug type, application, and region
• Information on stringent regulatory policies and government guidelines to impede the adoption rate of the psychedelic drugs
• Review of key marketed and pipelined products indicated for different therapeutic applications, clinical trials, and penetration of technologies and research initiatives within the ecosystem
• Company profiles of major players within the industry, including Pfizer Inc., Celon Pharma, Cybin Corp., Jazz Pharmaceuticals Inc., and PharmaTher Holdings Ltd.

Table of Contents

Chapter 1 Market Outlook

• 1.1 Market Snapshot

Chapter 2 Executive Summary

Chapter 3 Market Overview

• 3.1 Market Overview
• 3.2 Market Dynamics
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints

Chapter 4 Market Breakdown by Drug Type

• 4.1 Market by Drug Type
• 4.2 Ketamine
• 4.3 Gamma-hydroxybutyric Acid (GHB)
• 4.4 Others

Chapter 5 Market Breakdown by Application

• 5.1 Market, by Application
• 5.2 Resistant Depression and Anxiety
• 5.3 Opiate Addiction
• 5.4 Post-Traumatic Stress Disorder
• 5.5 Narcolepsy
• 5.6 Others

Chapter 6 Market Breakdown by Region

• 6.1 Global Market, by Region
• 6.2 North America
• 6.3 Europe
• 6.4 Asia-Pacific
• 6.5 Rest of the World

Chapter 7 Psychedelic Drugs and Precision Medicine

Chapter 8 Industry Structure

• 8.1 Company Rankings
• 8.2 Recent Key Developments

Chapter 9 Company Profiles

• CELON PHARMA S.A.
• CYBIN CORP.
• HIKMA PHARMACEUTICALS PLC.
• JAZZ PHARMACEUTICALS INC.
• MIND MEDICINE INC.
• PFIZER INC.
• PHARMATHER HOLDINGS LTD.
• REVIVE THERAPEUTICS LTD.

Chapter 10 Project Scope and Methodology

• 10.1 Scope of Report
• 10.2 Methodology
• 10.3 Analyst's Credentials
• 10.4 BCC Custom Research
• 10.5 Related BCC Research Reports